Cure SMA: Evaluation of SMA in the Era of Telehealth

Diana Castro, MD walks us through a pediatric neurological exam and notes examination findings that may be identified in an infant with Spinal Muscular Atrophy (SMA).

Garey H. Noritz, MDwalks us through a virtual pediatric neurological exam and notes examination findings that may be identified in an infant with Spinal Muscular Atrophy (SMA).

Screening of newborns for spinal muscular atrophy (SMA) has been implemented in 33 states. The signs and symptoms leading a pediatrician to a diagnosis of SMA are discussed.

Standardized screening is used by support staff to assess developmental milestones to assist in the recognition of spinal muscular atrophy (SMA).  

Targeting early recognition of spinal muscular atrophy (SMA) and referral to a neurologist is emphasized.

Garey H. Noritz, MD, stresses the value of in-person office visits for babies to ensure they receive their vaccinations and physical examination.

The workflow for a remote visit during COVID-19 is outlined.

Experts suggest what to look for during a virtual examination during COVID-19 that may suggest a diagnosis of spinal muscular atrophy (SMA). If SMA is suspected, they stress the importance of an evaluation, as soon as possible, with a neurologist.

Several spinal muscular atrophy (SMA) resources are suggested to help physicians and families: Cure SMA, SMArt Moves, SMA Standard of Care documents, and the Child Neurology Foundation’s Telehealth Tip Sheet.

Closing thoughts on advice to community pediatricians evaluating a baby for spinal muscular atrophy (SMA).